The Effect of Sevoflurane and Fullerenol C 60 on the Liver and Kidney in Lower Extremity Ischemia-Reperfusion Injury in Mice With Streptozocin-Induced Diabetes

Loading...
Publication Logo

Date

2023

Journal Title

Journal ISSN

Volume Title

Publisher

Dove Medical Press Ltd

Open Access Color

GOLD

Green Open Access

Yes

OpenAIRE Downloads

OpenAIRE Views

Publicly Funded

No
Impulse
Average
Influence
Average
Popularity
Top 10%

Research Projects

Journal Issue

Abstract

Objective: This study aimed to demonstrate whether fullerenol C60, sevoflurane anesthesia, or a combination of both had protective effects on the liver and kidneys in lower extremity ischemia-reperfusion injury (IRI) in mice with streptozocin-induced diabetes. Methods: A total of 46 Swiss albino mice were divided into six groups as follows: control group (group C, n=7), diabetes group (group D, n=7), diabetes-ischemia/reperfusion (group DIR, n=8), diabetes-ischemia/reperfusion-fullerenol C60 (group DIR-FC60, n=8), diabetes-ischemia/reperfusion-sevoflurane (group DIR-S, n=8), and the diabetes-ischemia/reperfusion-fullerenol C60-sevoflurane (group DIR-S-FC60, n=8). Fullerenol C60 (100mg/kg) was administered intraperitoneally 30 min before the ischemia-reperfusion procedure to the fullerenol groups (DIR-FC60 and DIR-S-FC60). In the DIR groups, 2 hours (h) ischemia-2h reperfusion periods were performed. In the sevoflurane groups, sevoflurane was applied during the ischemia-reperfusion period with 100% O2. Liver and kidney tissues were removed at the end of the reperfusion procedure for biochemical and histopathological examinations.Results: In liver tissue, hydropic degeneration, sinusoidal dilatation, pycnotic nuclei, prenecrotic cells, and mononuclear cell infiltration in parenchyma were significantly more frequent in group DIR than in groups D and group C. In terms of the histopathologic criteria examined, more positive results were seen in group DIR-FC60, and when group DIR-FC60 was compared with group DIR, the difference was significant. The best results in AST, ALT, glucose, TBARS levels, and SOD enzyme activities in liver tissue were in group DIR-FC60 compared with group DIR, followed by groups DIR-S-FC60 and DIR-S, respectively. Regarding TBARS levels and SOD enzyme activities in kidney tissue, the best results were in groups DIR-FC60, DIR-S-FC60, and DIR-S, respectively.Conclusion: According to our findings, it is clear that fullerenol C60 administered intraperitoneally 30 min before ischemia, alone or together with sevoflurane, reduces oxidative stress in distant organ damage caused by lower extremity IRI, and reduces liver and kidney tissue damage in histopathologic examinations.

Description

Küçük, Ayşegül/0000-0001-9316-9574; Sengel, Necmiye/0000-0001-8591-3658; Dursun, Ali Dogan/0000-0001-9056-0025; Ozdemir, Cagri/0000-0002-1266-8054; Arslan, Mustafa/0000-0003-4882-5063; Er, Fatma/0000-0003-3008-1764

Keywords

lower extremity, ischemia-reperfusion, diabetes, fullerenol C60, sevoflurane, kidney, liver, mice, kidney, Medicine (General), mice, sevoflurane, liver, Kidney, Thiobarbituric Acid Reactive Substances, ischemia-reperfusion, Streptozocin, Diabetes Mellitus, Experimental, Mice, Sevoflurane, R5-920, International Journal of Nanomedicine, Ischemia, Animals, Rats, Wistar, Original Research, diabetes, Superoxide Dismutase, fullerenol c60, Rats, Liver, Lower Extremity, lower extremity; ischemia-reperfusion; diabetes; fullerenol C60; sevoflurane; kidney; liver; mice, Reperfusion Injury, lower extremity

Fields of Science

0301 basic medicine, 03 medical and health sciences, 0303 health sciences

Citation

WoS Q

Q1

Scopus Q

Q1
OpenCitations Logo
OpenCitations Citation Count
N/A

Source

International Journal of Nanomedicine

Volume

18

Issue

Start Page

7543

End Page

7557

Collections

PlumX Metrics
Citations

Scopus : 15

PubMed : 6

Captures

Mendeley Readers : 7

SCOPUS™ Citations

15

checked on Feb 11, 2026

Web of Science™ Citations

15

checked on Feb 11, 2026

Page Views

3

checked on Feb 11, 2026

Google Scholar Logo
Google Scholar™
OpenAlex Logo
OpenAlex FWCI
5.35002128

Sustainable Development Goals

3

GOOD HEALTH AND WELL-BEING
GOOD HEALTH AND WELL-BEING Logo